-
Ascentage Pharma's EED inhibitor APG-5918 has been approved for Phase I clinical trial in China and will advance the clinical development of advanced solid tumors or hematologic malignancies
Time of Update: 2023-01-05
HK) announced on November 10 that APG-5918, a class 1 embryonic ectoderm development protein (EED) inhibitor under development, has been approved by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) to carry out phase I clinical trials for the treatment of advanced solid tumors or hematologic malignancies.
-
Biocytogen's self-developed bispecific antibody was approved by the FDA to enter clinical trials
Time of Update: 2022-12-30
js?cdnversion='+~(-new Date()/36e5)];Biocytogen (Beijing) Pharmaceutical Technology Co.
js?cdnversion='+~(-new Date()/36e5)];Biocytogen (Beijing) Pharmaceutical Technology Co.
js?cdnversion='+~(-new Date()/36e5)];Biocytogen (Beijing) Pharmaceutical Technology Co.
js?cdnversion='+~(-new Date()/36e5)];Biocytogen (Beijing) Pharmaceutical Technology Co.
-
Homeless people stole cables 18 times in succession, and the police investigated for three weeks and arrested the suspect
Time of Update: 2022-11-23
From the second half of last year to January this year, there have been many cases of cable theft on the road from Baoying Yunguang Lake to Yunshui, and the theft suspect only steals (100~200) meters of cable each time, and comes out once in a while.
-
Tesla's 100th charging station in China was completed
Time of Update: 2022-11-22
At the same time, Tesla's public charging partner program was fully launched to absorb the participation of social forces in the laying of the public charging network.
-
Issue 6, 2019 - FXI and INNOCOR merge to form a new company
Time of Update: 2022-11-11
" ”FXI and INNOCOR merge to form new company On March 5, two polyurethane foam product producers FXI and Innovor announced the signing of a definitive merger agreement to create a new company.
-
A group of common viruses closely related to type 1 diabetes
Time of Update: 2022-10-01
Ms Isaacs explains: "Our study found that patients with T1D who were both at genetic risk and had a first-degree relative of T1D were 29 times more likely to be infected with enteroviruses than other patients.
-
China Wuhuan joins hands with BASF and others to develop natural gas CO2-to-synthesis gas technology to help "double carbon
Time of Update: 2022-09-15
He said that combined with CNOOC's oil and gas resources development capabilities in the South China Sea, BASF's technological advantages in the field of decarbonization catalysts and China Wuhuan's process research and development in the chemical industry field And engineering practice advantages, we hope to seize this cooperation opportunity, establish a good strategic partnership, and cooperate to develop more green, low-carbon natural gas Wang Weimin, Secretary of the Party Committee and Chairman of CNOOC Petrochemical Co.
-
New technologies and new concepts to help control and alleviate diabetes
Time of Update: 2022-09-15
Audit Specialist:Professor Li Yanbing The First Affiliated Hospital of Sun Yat-sen UniversityWe have historically thought that type 2 diabetes mellitus (T2DM) is a progressive disease characterized by hyperglycemia that requires long-term glycemic control with hypoglycemic drugs.
-
Towards the salt water evening honey soup, "collection" season so healthy
Time of Update: 2022-09-08
(The author is deputy chief physician of the Department of Traditional Chinese Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine) Cold and summer come and go, autumn harvest and winter hiding, and in the blink of an eye, it is the season of "collection" of all things.
-
This additive is not simple, it solves the difficulty of product coding and improves the efficiency of the supply chain
Time of Update: 2022-08-25
Masterbatch additives work with standard CO2 scribing lasers to provide sustainability benefits in production environments by eliminating labels, consumables and scrap from the encoding and marking process compared to other encoding methods .
-
China Bluestar's new generation of polyphenylene ether products are on the market
Time of Update: 2022-06-16
"Wang Yongbin also introduced: " In addition, Bluestar's new generation of polyphenylene ether products also have the characteristics of low oligomer content and less mold scale precipitation.
-
Explore more and look forward to the new future of diabetes management
Time of Update: 2022-06-14
Some GLP-1RAs represented by glutide drugs have cardiovascular protective effects while effectively lowering blood sugar, which is an ideal choice for diabetic patients .
-
Laboratory safety management (1
Time of Update: 2022-02-06
Figure 12-1 Fire caused by improper chemical storageThe main content of on-site safety management is to find hidden dangers to orderly standardize various management functions, including the orderly standardization of material control, the orderly standardization of human operations and various behaviors, the orderly standardization of the human health environment and the production environment.
-
China National Medical Products Administration Approves Baizean(R) for Second-Line or Third-Line Treatment of Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Time of Update: 2022-01-26
The company announced today that the China National Medical Products Administration (NMPA) has approved BeiGene's anti-PD-1 antibody drug Baizean® ( tislelizumab injection) for locally advanced or metastatic non-small cell lung cancer Second- or third-line therapy for patients with NSCLC .
-
Clariant completes the sale of its pigment business
Time of Update: 2022-01-07
Clariant , a dedicated, sustainable and innovative specialty chemical company, January 4 Clariant has carried over a consideration of approximately 115 million Swiss francs in order to continue to hold a 20% stake in the new holding company, and will jointly hold shares with Heubach and SK Capital in the future .
